Skip to main
NEOG

Neogen (NEOG) Stock Forecast & Price Target

Neogen (NEOG) Analyst Ratings

Based on 3 analyst ratings
Buy
Strong Buy 33%
Buy 33%
Hold 33%
Sell 0%
Strong Sell 0%

Bulls say

Neogen Corporation's strong position in the food and animal safety sectors is bolstered by its recent acquisition, which has enhanced its market presence and potential for future growth. The company's comprehensive range of products, including diagnostics and veterinary solutions, demonstrates its commitment to addressing critical safety concerns in both food and animal health markets. Despite facing potential risks such as competition and supply chain disruptions, Neogen's strategic focus on internal growth and acquisitions positions it favorably for continued performance and resilience.

Bears say

Neogen Corporation's recent financial performance has exhibited challenges, particularly in its revenue growth, which may be attributed to increased competition in the food and animal safety sectors. Additionally, rising costs associated with research and development, along with supply chain disruptions, have impacted profit margins, contributing to an overall negative outlook. Furthermore, a decline in demand for certain products, exacerbated by economic conditions and shifts in consumer behavior, raises concerns about the company's future financial stability.

Neogen (NEOG) has been analyzed by 3 analysts, with a consensus rating of Buy. 33% of analysts recommend a Strong Buy, 33% recommend Buy, 33% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Neogen and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Neogen (NEOG) Forecast

Analysts have given Neogen (NEOG) a Buy based on their latest research and market trends.

According to 3 analysts, Neogen (NEOG) has a Buy consensus rating as of Jan 21, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $10.67, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $10.67, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Neogen (NEOG)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.